SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549






FORM 8-K/A



CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934





Date of Report (Date of earliest event reported): May 7, 2004





Arrhythmia Research Technology, Inc.
(Exact name of issuer as specified in its charter)


Delaware 1-9731 72-0925679
(State or other jurisdiction of
Incorporation or organization)		 (Commission File Number) (I.R.S. Employer Identification Number)



25 Sawyer Passway
Fitchburg, MA 01420
(Address of principal executive offices and zip code)




(978) 345-5000
(Registrant’s telephone number, including area code)

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits

               (b)   Pro forma financial information: Not Applicable




SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Fitchburg, Commonwealth of Massachusetts, on the 21st day of July 2004.

  ARRHYTHMIA RESEARCH TECHNOLOGY, INC.
     
    By: /s/ David A. Garrison
    David A. Garrison
    Chief Financial Officer